Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs-Reference-Cited by-同舟云学术

Analysis of A2a receptor-deficient mice reveals no significant compensatory increases in the expression of A2b, A1, and A3 adenosine receptors in lymphoid organs

Published:2003-06 Issue:12 Volume:65 Page:2081-2090
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Lukashev Dmitriy E,Smith Patrick T,Caldwell Charles C,Ohta Akio,Apasov Sergey G,Sitkovsky Michail V

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference25 articles.

1. Regulation of cytokine gene transcription in the immune system;Holloway;Mol. Immunol.,2002

2. Arthritis and sepsis caused by Staphylococcus aureus: can the tissue injury be reduced by modulating the host’s immune system;Tarkowski;Mol. Med. Today,1998

3. Chronic inflammation and cancer;Shacter;Oncology (Huntingt.),2002

4. Adenosine A2A receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model;McPherson;Arterioscler. Thromb. Vasc. Biol.,2001

5. Heat shock proteins, inflammation, and cardiovascular disease;Pockley;Circulation,2002

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential pharmaceuticals targeting neuroimmune interactions in treating acute lung injury;Clinical and Translational Medicine;2024-08

2. Regulatory T cells as crucial trigger and potential target for hyperprogressive disease subsequent to PD-1/PD-L1 blockade for cancer treatment;International Immunopharmacology;2024-05

3. Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies;Journal of Biomedical Science;2024-01-12

4. Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance;Cancer Cell;2023-10

5. Cupping alleviates lung injury through the adenosine/A2BAR pathway;Heliyon;2022-12